TPX-EGCG

N/A

Report date: 2025/01/26 17:07:26
NME

Base Information

Drug NameTPX-EGCG
Drug Alias NameEGCG(Therapyx)epigallocatechin gallate(Therapyx)TPX-EGCG
ClassificationSmall moleculesNatural product/Extract
Mechanisms of ActionInterleukin-6 inhibitorsP38 α mitogen-activated protein kinase inhibitorsc-Jun N-terminal kinase inhibitors
Targetsc-Jun N-terminal kinaseInterleukin-6P38 α mitogen-activated protein kinase
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTherapyX Inc
China Registration ClassN/A

Develop Information

Active CompaniesTherapyX Inc
Inactive CompaniesN/A
Active IndicationsInflammation
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A